People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clovis Oncology, Inc. | — | Pharmaceuticals | Series D+ | $358.3M | $6.8B | 2013 |
| TriSalus Life Sciences, Inc. | — | Other Health Care | Series C | $209.1M | $145.1M | 2011 |
Ginger L. Graham at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ginger L. Graham on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian G. Atwood | 1 | 8 |
| James C. Blair | 1 | 8 |
| James Young | 1 | 4 |
| CHRISTOPHER C DEWEY | 1 | 4 |
| Mary T. Szela | 1 | 4 |
| Norman R. Weldon | 1 | 3 |
| James Chomas | 1 | 3 |
| Erle T. Mast | 1 | 3 |
| Mats J. Wahlstrom | 1 | 3 |
| Mary Szela | 1 | 3 |
| Mark J. Lupa | 1 | 2 |
| Karim Karti | 1 | 2 |
| DIANE PARKS | 1 | 2 |
| Mats R Wahlstrom | 1 | 2 |
| Patrick J. Mahaffy | 1 | 2 |
| Gene McGrevin | 1 | 2 |
| Mark L. Lupa | 1 | 1 |
| Miles J. Gerson | 1 | 1 |
| Andrew R. Allen | 1 | 1 |
| John R. Tullis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.